<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34905407</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8976</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Season>Jan-Feb</Season></PubDate></JournalIssue><Title>Viral immunology</Title><ISOAbbreviation>Viral Immunol</ISOAbbreviation></Journal><ArticleTitle>Controlling the Burden of COVID-19 by Manipulating Host Metabolism.</ArticleTitle><Pagination><StartPage>24</StartPage><EndPage>32</EndPage><MedlinePgn>24-32</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/vim.2021.0150</ELocationID><Abstract><AbstractText>The coronavirus disease 2019 (COVID-19) pandemic caused by the coronavirus-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to cause global health problems, but its impact would be minimized if the many effective vaccines that have been developed were available and in widespread use by all societies. This ideal situation is not occurring so other means of controlling COVID-19 are needed. In this short review, we make the case that manipulating host metabolic pathways could be a therapeutic approach worth exploring. The rationale for such an approach comes from the fact that viruses cause metabolic changes in cells they infect, effective host defense mechanisms against viruses requires the activity of one or more metabolic pathways, and that hosts with metabolic defects such as diabetes are more susceptible to severe consequences after COVID-19. We describe the types of approaches that could be used to redirect various aspects of host metabolism and the success that some of these maneuvers have had at controlling other virus infections. Manipulating metabolic activities to control the outcome of COVID-19 has to date received minimal attention. Manipulating host metabolism will never replace vaccines to control COVID-19 but could be used as an adjunct therapy to the extent of ongoing infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Logan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berber</LastName><ForeName>Engin</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sumbria</LastName><ForeName>Deepak</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouse</LastName><ForeName>Barry T</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 AI142862</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 EY005093</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Viral Immunol</MedlineTA><NlmUniqueID>8801552</NlmUniqueID><ISSNLinking>0882-8245</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017281" MajorTopicYN="Y">Cost of Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">consequence</Keyword><Keyword MajorTopicYN="N">immunity</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">metabolism</Keyword><Keyword MajorTopicYN="N">outcome</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>14</Day><Hour>17</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34905407</ArticleId><ArticleId IdType="pmc">PMC8863913</ArticleId><ArticleId IdType="doi">10.1089/vim.2021.0150</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Acharya D, Liu G, and Gack MU. Dysregulation of type I interferon responses in COVID-19. Nat Rev Immunol 2020;20:397&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7249038</ArticleId><ArticleId IdType="pubmed">32457522</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Ampudia Y, Monsalve DM, Rojas M, et al. . COVID-19 convalescent plasma composition and immunological effects in severe patients. J Autoimmun 2021;118:102598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7826092</ArticleId><ArticleId IdType="pubmed">33524876</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajaz S, McPhail MJ, Singh KK, et al. . Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19. Am J Physiol Cell Physiol 2021;320:C57&#x2013;c65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7816428</ArticleId><ArticleId IdType="pubmed">33151090</ArticleId></ArticleIdList></Reference><Reference><Citation>Alavi Darazam I, Shokouhi S, Pourhoseingholi MA, et al. . Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial. Sci Rep 2021;11:8059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8044200</ArticleId><ArticleId IdType="pubmed">33850184</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Khatib HA, Benslimane FM, Elbashir IE, et al. . Within-host diversity of SARS-CoV-2 in COVID-19 patients with variable disease severities. Front Cell Infect Microbiol 2020;10:575613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7572854</ArticleId><ArticleId IdType="pubmed">33123498</ArticleId></ArticleIdList></Reference><Reference><Citation>Antunes KH, Fachi JL, de Paula R, et al. . Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response. Nat Commun 2019;10:3273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6646332</ArticleId><ArticleId IdType="pubmed">31332169</ArticleId></ArticleIdList></Reference><Reference><Citation>Atri D, Siddiqi HK, Lang JP, et al. . COVID-19 for the cardiologist. JACC Basic Transl Sci 2020;5:518&#x2013;536.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7151394</ArticleId><ArticleId IdType="pubmed">32292848</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayres JS. A metabolic handbook for the COVID-19 pandemic. Nat Metab 2020;2:572&#x2013;585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7325641</ArticleId><ArticleId IdType="pubmed">32694793</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassatne A, Basbous M, Chakhtoura M, et al. . The link between COVID-19 and VItamin D (VIVID): a systematic review and meta-analysis. Metabolism 2021;119:154753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7989070</ArticleId><ArticleId IdType="pubmed">33774074</ArticleId></ArticleIdList></Reference><Reference><Citation>Belkaid Y, and Harrison OJ. Homeostatic immunity and the microbiota. Immunity 2017;46:562&#x2013;576.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5604871</ArticleId><ArticleId IdType="pubmed">28423337</ArticleId></ArticleIdList></Reference><Reference><Citation>Berber E, Sumbria D, Newkirk KM, et al. . Inhibiting glucose metabolism results in herpes simplex encephalitis. J Immunol Res 2021;207:1824&#x2013;1835.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8455457</ArticleId><ArticleId IdType="pubmed">34470854</ArticleId></ArticleIdList></Reference><Reference><Citation>Berber E, Sumbria D, and Rouse BT. Could targeting immunometabolism be a way to control the burden of COVID-19 infection? Microbes Infect 2021;23:104780.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7816601</ArticleId><ArticleId IdType="pubmed">33482357</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishehsari F, Engen PA, and Preite NZ. Dietary fiber treatment corrects the composition of gut microbiota, promotes SCFA production, and suppresses colon carcinogenesis. Genes (Basel) 2018;9:102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5852598</ArticleId><ArticleId IdType="pubmed">29462896</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojkova D, Costa R, Reus P, et al. . Targeting the pentose phosphate pathway for SARS-CoV-2 therapy. Metabolites 2021;11:699.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8540749</ArticleId><ArticleId IdType="pubmed">34677415</ArticleId></ArticleIdList></Reference><Reference><Citation>Breman JG, and Henderson DA. Diagnosis and management of smallpox. N Engl J Med 2002;346:1300&#x2013;1308.</Citation><ArticleIdList><ArticleId IdType="pubmed">11923491</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruzzone C, Bizkarguenaga M, Gil-Redondo R, et al. . SARS-CoV-2 infection dysregulates the metabolomic and lipidomic profiles of serum. iScience 2020;23:101645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534591</ArticleId><ArticleId IdType="pubmed">33043283</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Q, Chen F, Wang T, et al. . Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Diabetes Care 2020;43:1392&#x2013;1398.</Citation><ArticleIdList><ArticleId IdType="pubmed">32409502</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F, and Perego E. How and why patients made long COVID. Soc Sci Med 2021;268:113426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrasco-S&#xe1;nchez FJ, L&#xf3;pez-Carmona MD, Mart&#xed;nez-Marcos FJ, et al. . Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 registry. Ann Med 2021;53:103&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7651248</ArticleId><ArticleId IdType="pubmed">33063540</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruso R, Lo BC, and N&#xfa;&#xf1;ez G. Host&#x2013;microbiota interactions in inflammatory bowel disease. Nat Rev Immunol 2020;20:411&#x2013;426.</Citation><ArticleIdList><ArticleId IdType="pubmed">32005980</ArticleId></ArticleIdList></Reference><Reference><Citation>Caterino M, Costanzo M, Fedele R, et al. . The serum metabolome of moderate and severe COVID-19 patients reflects possible liver alterations involving carbon and nitrogen metabolism. Int J Mol Sci 2021;22:9548.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8431319</ArticleId><ArticleId IdType="pubmed">34502454</ArticleId></ArticleIdList></Reference><Reference><Citation>Caussy C, Pattou F, Wallet F, et al. . Prevalence of obesity among adult inpatients with COVID-19 in France. Lancet Diabetes Endocrinol 2020;8:562&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234780</ArticleId><ArticleId IdType="pubmed">32437642</ArticleId></ArticleIdList></Reference><Reference><Citation>Cengiz M, Borku Uysal B, Ikitimur H, et al. . Effect of oral l-Glutamine supplementation on Covid-19 treatment. Clin Nutr Exp 2020;33:24&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7387270</ArticleId><ArticleId IdType="pubmed">32835086</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty C, Sharma AR, Bhattacharya M, et al. . COVID-19: consider IL-6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients. J Med Virol 2020;92:2260&#x2013;2262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7283789</ArticleId><ArticleId IdType="pubmed">32462717</ArticleId></ArticleIdList></Reference><Reference><Citation>Chirizzi D, Conte M, Feltracco M, et al. . SARS-CoV-2 concentrations and virus-laden aerosol size distributions in outdoor air in north and south of Italy. Environ Int 2021;146:106255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7659514</ArticleId><ArticleId IdType="pubmed">33221596</ArticleId></ArticleIdList></Reference><Reference><Citation>Codo AC, Davanzo GG, Monteiro LB, et al. . Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1&#x3b1;/glycolysis-dependent axis. Cell Metab 2020;32:437&#x2013;446.e435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7367032</ArticleId><ArticleId IdType="pubmed">32697943</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper MH, Christensen PA, Salazar E, et al. . Real-world assessment of 2,879 COVID-19 patients treated with monoclonal antibody therapy: a propensity score-matched cohort study. Open Forum Infect Dis 2021;8:ofab512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9088516</ArticleId><ArticleId IdType="pubmed">35559124</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels BP, Kofman SB, Smith JR, et al. . The nucleotide sensor ZBP1 and kinase RIPK3 induce the enzyme IRG1 to promote an antiviral metabolic state in neurons. Immunity 2019;50:64&#x2013;76.e64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6342485</ArticleId><ArticleId IdType="pubmed">30635240</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021;38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado T, Sanchez EL, Camarda R, et al. . Global metabolic profiling of infection by an oncogenic virus: KSHV induces and requires lipogenesis for survival of latent infection. PLoS Pathog 2012;8:e1002866.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3420960</ArticleId><ArticleId IdType="pubmed">22916018</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lucena TMC, da Silva Santos AF, de Lima BR, et al. . Mechanism of inflammatory response in associated comorbidities in COVID-19. Diabetes Metab Syndr 2020;14:597&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7215143</ArticleId><ArticleId IdType="pubmed">32417709</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai HR, Sivasubramaniyam T, Revelo XS, et al. . Macrophage JAK2 deficiency protects against high-fat diet-induced inflammation. Sci Rep 2017;7:7653.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5550513</ArticleId><ArticleId IdType="pubmed">28794431</ArticleId></ArticleIdList></Reference><Reference><Citation>Dias SSG, Soares VC, Ferreira AC, et al. . Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators. PLoS Pathog 2020;16:e1009127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7773323</ArticleId><ArticleId IdType="pubmed">33326472</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreher M, Kersten A, Bickenbach J, et al. . The characteristics of 50 hospitalized COVID-19 patients with and without ARDS. Dtsch Arztebl Int 2020;117:271&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7171478</ArticleId><ArticleId IdType="pubmed">32519944</ArticleId></ArticleIdList></Reference><Reference><Citation>Ero&#x11f;lu &#x130;, Ero&#x11f;lu B&#xc7;, and G&#xfc;ven GS. Altered tryptophan absorption and metabolism could underlie long-term symptoms in survivors of coronavirus disease 2019 (COVID-19). Nutrition 2021;90:111308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8087860</ArticleId><ArticleId IdType="pubmed">34111831</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang L, Karakiulakis G, and Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 2020;8:e21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118626</ArticleId><ArticleId IdType="pubmed">32171062</ArticleId></ArticleIdList></Reference><Reference><Citation>Fignani D, Licata G, Brusco N, et al. . SARS-CoV-2 receptor angiotensin i-converting enzyme type 2 (ACE2) is expressed in human pancreatic &#x3b2;-cells and in the human pancreas microvasculature. Front Endocrinol (Lausanne) 2020;11:596898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7691425</ArticleId><ArticleId IdType="pubmed">33281748</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadiparthi C, Bassi M, Yegneswaran B, et al. . Hyperglycemia, hypertriglyceridemia, and acute pancreatitis in COVID-19 infection: clinical implications. Pancreas 2020;49:e62&#x2013;e63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7375186</ArticleId><ArticleId IdType="pubmed">32604205</ArticleId></ArticleIdList></Reference><Reference><Citation>Galeotti C, and Bayry J. Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol 2020;16:413&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7271827</ArticleId><ArticleId IdType="pubmed">32499548</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi M and Rutherford GW. Facial masking for covid-19&#x2014;potential for &#x201c;variolation&#x201d; as we await a vaccine. N Engl J Med 2020;383:e101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7890559</ArticleId><ArticleId IdType="pubmed">32897661</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghaffari H, Tavakoli A, Moradi A, et al. . Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine. J Biomed Sci 2019;26:70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6734352</ArticleId><ArticleId IdType="pubmed">31500628</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray N, Lawler NG, Zeng AX, et al. . Diagnostic potential of the plasma lipidome in infectious disease: application to acute SARS-CoV-2 infection. Metabolites 2021;11:467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8306636</ArticleId><ArticleId IdType="pubmed">34357361</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffith DA, Kung DW, Esler WP, et al. . Decreasing the rate of metabolic ketone reduction in the discovery of a clinical acetyl-CoAcarboxylase inhibitor for the treatment of diabetes. J Med Chem 2014;57:10512&#x2013;10526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4281100</ArticleId><ArticleId IdType="pubmed">25423286</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo B, Zhang W, Xu S, et al. . GSK-3&#x3b2; mediates dexamethasone-induced pancreatic &#x3b2; cell apoptosis. Life Sci 2016;144:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4703461</ArticleId><ArticleId IdType="pubmed">26606859</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Li M, Dong Y, et al. . Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev 2020;36:e3319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228407</ArticleId><ArticleId IdType="pubmed">32233013</ArticleId></ArticleIdList></Reference><Reference><Citation>Heaton NS. Revisiting the concept of a cytopathic viral infection. PLoS Pathog 2017;13:e1006409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5519205</ArticleId><ArticleId IdType="pubmed">28727844</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou YJ, Okuda K, Edwards CE, et al. . SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell 2020;182:429&#x2013;446.e414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7250779</ArticleId><ArticleId IdType="pubmed">32526206</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafar N, Edriss H, and Nugent K. The effect of short-term hyperglycemia on the innate immune system. Am J Med Sci 2016;351:201&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">26897277</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafarzadeh A, Chauhan P, Saha B, et al. . Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: lessons from SARS and MERS, and potential therapeutic interventions. Life Sci 2020;257:118102&#x2013;118102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7367812</ArticleId><ArticleId IdType="pubmed">32687918</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagannathan M, McDonnell M, Liang Y, et al. . Toll-like receptors regulate B cell cytokine production in patients with diabetes. Diabetologia 2010;53:1461&#x2013;1471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2895399</ArticleId><ArticleId IdType="pubmed">20383694</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaggi U, Varanasi SK, Bhela S, et al. . On the role of retinoic acid in virus induced inflammatory response in cornea. Microbes Infect 2018;20:337&#x2013;345.</Citation><ArticleIdList><ArticleId IdType="pubmed">29842984</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez de Oya N, Esler WP, Huard K, et al. . Targeting host metabolism by inhibition of acetyl-coenzyme A carboxylase reduces flavivirus infection in mouse models. Emerg Microbes Infect 2019;8:624&#x2013;636.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6493301</ArticleId><ArticleId IdType="pubmed">30999821</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi MB, Lad A, Bharath Prasad AS, et al. . High glucose modulates IL-6 mediated immune homeostasis through impeding neutrophil extracellular trap formation. FEBS Lett 2013;587:2241&#x2013;2246.</Citation><ArticleIdList><ArticleId IdType="pubmed">23735697</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan FA, Stewart I, Fabbri L, et al. . Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19. Thorax 2021;76:907&#x2013;919.</Citation><ArticleIdList><ArticleId IdType="pubmed">33579777</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JH, Park K, Lee SB, et al. . Relationship between natural killer cell activity and glucose control in patients with type 2 diabetes and prediabetes. J Diabetes Investig 2019;10:1223&#x2013;1228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6717814</ArticleId><ArticleId IdType="pubmed">30618112</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JY, Lim K, Kim KH, et al. . N-3 polyunsaturated fatty acids restore Th17 and Treg balance in collagen antibody-induced arthritis. PLoS One 2018;13:e0194331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5854360</ArticleId><ArticleId IdType="pubmed">29543869</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiselar JG, Wang X, Dubyak GR, et al. . Modification of &#x3b2;-defensin-2 by dicarbonyls methylglyoxal and glyoxal inhibits antibacterial and chemotactic function in vitro. PLoS One 2015;10:e0130533.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4526640</ArticleId><ArticleId IdType="pubmed">26244639</ArticleId></ArticleIdList></Reference><Reference><Citation>Korytkowski M, Antinori-Lent K, Drincic A, et al. . A pragmatic approach to inpatient diabetes management during the COVID-19 pandemic. J Clin Endocrinol Metab 2020;105:dgaa342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7313952</ArticleId><ArticleId IdType="pubmed">32498085</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, &#xc7;al&#x131;&#x15f;kan DM, Janowski J, et al. . Beyond vaccines: clinical status of prospective COVID-19 therapeutics. Front Immunol 2021;12:752227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8519339</ArticleId><ArticleId IdType="pubmed">34659259</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyriazopoulou E, Huet T, Cavalli G, et al. . Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis. Lancet Rheumatol 2021;3:e690&#x2013;e697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352496</ArticleId><ArticleId IdType="pubmed">34396156</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawler NG, Gray N, Kimhofer T, et al. . Systemic perturbations in amine and kynurenine metabolism associated with acute SARS-CoV-2 infection and inflammatory cytokine responses. J Proteome Res 2021;20:2796&#x2013;2811.</Citation><ArticleIdList><ArticleId IdType="pubmed">33724837</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D. Yellow fever and the slave trade: coleridge's &#x201c;the rime of the ancient mariner.&#x201d; ELH 1998;65:675&#x2013;700.</Citation></Reference><Reference><Citation>Lee W, Ahn JH, Park HH, et al. . COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm. Signal Transduct Target Ther 2020;5:186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471497</ArticleId><ArticleId IdType="pubmed">32883951</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G, Fan Y, Lai Y, et al. . Coronavirus infections and immune responses. J Med Virol 2020;92:424&#x2013;432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7166547</ArticleId><ArticleId IdType="pubmed">31981224</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Wei Q, Li WX, et al. . Metformin use in diabetes prior to hospitalization: effects on mortality in Covid-19. Endocr Pract 2020;26:1166&#x2013;1172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834011</ArticleId><ArticleId IdType="pubmed">33471718</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R, and Nikolajczyk BS. Tissue immune cells fuel obesity-associated inflammation in adipose tissue and beyond. Front Immunol 2019;10:1587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6653202</ArticleId><ArticleId IdType="pubmed">31379820</ArticleId></ArticleIdList></Reference><Reference><Citation>Magee MJ, Salindri AD, Kyaw NTT, et al. . Stress hyperglycemia in patients with tuberculosis disease: epidemiology and clinical implications. Curr Diabetes Rep 2018;18:71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6309553</ArticleId><ArticleId IdType="pubmed">30090969</ArticleId></ArticleIdList></Reference><Reference><Citation>Manivannan S, Baxter VK, Schultz KL, et al. . Protective effects of glutamine antagonist 6-Diazo-5-Oxo-l-norleucine in mice with alphavirus encephalomyelitis. J Virol 2016;90:9251&#x2013;9262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5044826</ArticleId><ArticleId IdType="pubmed">27489275</ArticleId></ArticleIdList></Reference><Reference><Citation>Marik PE, and Bellomo R.. Stress hyperglycemia: an essential survival response! Crit Care (London, England) 2013;17:305&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3672537</ArticleId><ArticleId IdType="pubmed">23470218</ArticleId></ArticleIdList></Reference><Reference><Citation>Marini JJ, and Gattinoni L. Management of COVID-19 respiratory distress. JAMA 2020;323:2329&#x2013;2330.</Citation><ArticleIdList><ArticleId IdType="pubmed">32329799</ArticleId></ArticleIdList></Reference><Reference><Citation>Martineau AR, and Forouhi NG. Vitamin D for COVID-19: a case to answer? Lancet Diabetes Endocrinol 2020;8:735&#x2013;736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7398646</ArticleId><ArticleId IdType="pubmed">32758429</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuyama T, Yoshinaga SK, Shibue K, et al. . Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19. Cell Death Differ 2021;28:3199&#x2013;3213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8522258</ArticleId><ArticleId IdType="pubmed">34663907</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurya R, Sebastian P, Namdeo M, et al. . COVID-19 severity in obesity: leptin and inflammatory cytokine interplay in the link between high morbidity and mortality. Front Immunol 2021;12:649359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250137</ArticleId><ArticleId IdType="pubmed">34220807</ArticleId></ArticleIdList></Reference><Reference><Citation>Men&#xe9;ndez-Arias L. Decoding molnupiravir-induced mutagenesis in SARS-CoV-2. J Biol Chem 2021;297:100867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8188802</ArticleId><ArticleId IdType="pubmed">34118236</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills EL, Ryan DG, Prag HA, et al. . Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 2018;556:113&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6047741</ArticleId><ArticleId IdType="pubmed">29590092</ArticleId></ArticleIdList></Reference><Reference><Citation>Milner JJ, Rebeles J, Dhungana S, et al. . Obesity increases mortality and modulates the lung metabolome during pandemic H1N1 influenza virus infection in mice. J Immunol 2015;194:4846&#x2013;4859.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4417391</ArticleId><ArticleId IdType="pubmed">25862817</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf8;rkholt AS, Kastaniegaard K, Trabjerg MS, et al. . Identification of brain antigens recognized by autoantibodies in experimental autoimmune encephalomyelitis-induced animals treated with etomoxir or interferon-&#x3b2;. Sci Rep 2018;8:7092.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5935685</ArticleId><ArticleId IdType="pubmed">29728570</ArticleId></ArticleIdList></Reference><Reference><Citation>Muniangi-Muhitu H, Akalestou E, Salem V, et al. . COVID-19 and diabetes: a complex bidirectional relationship. Front Endocrinol (Lausanne) 2020;11:582936.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7578412</ArticleId><ArticleId IdType="pubmed">33133024</ArticleId></ArticleIdList></Reference><Reference><Citation>Munn DH, and Mellor AL. Indoleamine 2,3 Dioxygenase and metabolic control of immune responses. Trends Immunol 2013;34:137&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3594632</ArticleId><ArticleId IdType="pubmed">23103127</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardacci R, Colavita F, Castilletti C, et al. . Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis. Cell Death Dis 2021;12:263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7952828</ArticleId><ArticleId IdType="pubmed">33712574</ArticleId></ArticleIdList></Reference><Reference><Citation>Noreen S, Maqbool I, and Madni A. Dexamethasone: therapeutic potential, risks, and future projection during COVID-19 pandemic. Eur J Pharmacol 2021;894:173854.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836247</ArticleId><ArticleId IdType="pubmed">33428898</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Donnell JS, and Chappell KJ. Chronic SARS-CoV-2, a cause of post-acute COVID-19 sequelae (Long-COVID)? Front Immunol 2021;12:724654.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8365243</ArticleId><ArticleId IdType="pubmed">34408742</ArticleId></ArticleIdList></Reference><Reference><Citation>Olagnier D, Farahani E, Thyrsted J, et al. . SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate. Nat Commun 2020;11:4938.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7532469</ArticleId><ArticleId IdType="pubmed">33009401</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Neill LAJ, and Artyomov MN. Itaconate: the poster child of metabolic reprogramming in macrophage function. Nat Rev Immunol 2019;19:273&#x2013;281.</Citation><ArticleIdList><ArticleId IdType="pubmed">30705422</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr&#xf9; G, Bertelloni D, Diolaiuti F, et al. . Long-COVID syndrome? A study on the persistence of neurological, psychological and physiological symptoms. Healthcare (Basel) 2021;9:e9050575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8152255</ArticleId><ArticleId IdType="pubmed">34068009</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Shea D, and Hogan AE. Dysregulation of natural killer cells in obesity. Cancers (Basel) 2019;11:573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6521109</ArticleId><ArticleId IdType="pubmed">31018563</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe1;ez-Franco JC, Torres-Ruiz J, Sosa-Hern&#xe1;ndez VA, et al. . Metabolomics analysis reveals a modified amino acid metabolism that correlates with altered oxygen homeostasis in COVID-19 patients. Sci Rep 2021;11:6350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7973513</ArticleId><ArticleId IdType="pubmed">33737694</ArticleId></ArticleIdList></Reference><Reference><Citation>Parada Venegas D, De la Fuente MK, Landskron G, et al. . Short chain fatty acids (SCFAS)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol 2019;10:277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6421268</ArticleId><ArticleId IdType="pubmed">30915065</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson KB, and Runge T. Smallpox and the native American. Am J Med Sci 2002;323:216&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pubmed">12003378</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson KD, and Pyle GF. The geography and mortality of the 1918 influenza pandemic. Bull Hist Med 1991;65:4&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">2021692</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearce-Duvet JMC. The origin of human pathogens: evaluating the role of agriculture and domestic animals in the evolution of human disease. Biol Rev 2006;81:369&#x2013;382.</Citation><ArticleIdList><ArticleId IdType="pubmed">16672105</ArticleId></ArticleIdList></Reference><Reference><Citation>Perner A, Nielsen SE, and Rask-Madsen J. High glucose impairs superoxide production from isolated blood neutrophils. Intensive Care Med 2003;29:642&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pubmed">12552364</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollock AM, and Lancaster J. Asymptomatic transmission of COVID-19. BMJ 2020;371:m4851.</Citation></Reference><Reference><Citation>Popkin BM, Du S, Green WD, et al. . Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships. Obes Rev 2020;21:e13128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461480</ArticleId><ArticleId IdType="pubmed">32845580</ArticleId></ArticleIdList></Reference><Reference><Citation>Ran J, Zhao S, Han L, et al. . Increase in diabetes mortality associated with COVID-19 pandemic in the U.S. Diabetes Care 2021;44:e146&#x2013;e147.</Citation><ArticleIdList><ArticleId IdType="pubmed">34135014</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds CJ, Pade C, Gibbons JM, et al. . Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose. Science 2021;372:1418&#x2013;1423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8168614</ArticleId><ArticleId IdType="pubmed">33931567</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozga M, Cheng FW, Moloney L, et al. . Effects of micronutrients or conditional amino acids on COVID-19-related outcomes: an evidence analysis center scoping review. J Acad Nutr Diet 2021;121:1354&#x2013;1363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7237946</ArticleId><ArticleId IdType="pubmed">32565398</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez EL, and Lagunoff M. Viral activation of cellular metabolism. Virology 2015;479&#x2013;480:609&#x2013;618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4424078</ArticleId><ArticleId IdType="pubmed">25812764</ArticleId></ArticleIdList></Reference><Reference><Citation>Sehrawat S, and Rouse BT. COVID-19: disease, or no disease?&#x2014;That is the question. It's the dose stupid! Microbes Infect 2021;23:104779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832071</ArticleId><ArticleId IdType="pubmed">33450356</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonnet A, Chetboun M, Poissy J, et al. . High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring) 2020;28:1195&#x2013;1199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262326</ArticleId><ArticleId IdType="pubmed">32271993</ArticleId></ArticleIdList></Reference><Reference><Citation>Sindelar M, Stancliffe E, Schwaiger-Haber M, et al. . Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity. Cell Rep Med 2021;2:100369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8292035</ArticleId><ArticleId IdType="pubmed">34308390</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith M, Honce R, and Schultz-Cherry S. Metabolic syndrome and viral pathogenesis: lessons from influenza and coronaviruses. J Virol 2020;94:e00665&#x2013;00620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7459568</ArticleId><ArticleId IdType="pubmed">32661141</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J-W, Lam SM, Fan X, et al. . Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis. Cell Metabol 2020;32:188&#x2013;202.e185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7311890</ArticleId><ArticleId IdType="pubmed">32610096</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock C, Richter S, Berger I, et al. . Viral infiltration of pancreatic islets in patients with COVID-19. Nat Commun 2021;12:3534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8192507</ArticleId><ArticleId IdType="pubmed">34112801</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of long COVID. Nat Med 2021;27:626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumbria D, Berber E, Mathayan M, et al. . Virus infections and host metabolism&#x2014;can we manage the interactions? Front Immunol 2021;11:594963.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7887310</ArticleId><ArticleId IdType="pubmed">33613518</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumbria D, Berber E, Miller L, et al. . Modulating glutamine metabolism to control viral immuno-inflammatory lesions. Cell Immunol 2021;370:104450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8656366</ArticleId><ArticleId IdType="pubmed">34678554</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumbria D, Berber E, and Rouse BT. Supplementing the diet with sodium propionate suppresses the severity of viral immuno-inflammatory lesions. J Virol 2021;95:e02056&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7851545</ArticleId><ArticleId IdType="pubmed">33208449</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaker SK, Ch'ng J, and Christofk HR. Viral hijacking of cellular metabolism. BMC Biol 2019;17:59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6637495</ArticleId><ArticleId IdType="pubmed">31319842</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC, Cholevas C, Polyzoidis K, et al. . Long-COVID syndrome-associated brain fog and chemofog: luteolin to the rescue. BioFactors 2021;47:232&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250989</ArticleId><ArticleId IdType="pubmed">33847020</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T, Stefanoni D, Reisz JA, et al. . COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight 2020;5:e140327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7453907</ArticleId><ArticleId IdType="pubmed">32559180</ArticleId></ArticleIdList></Reference><Reference><Citation>Trasino SE. A role for retinoids in the treatment of COVID-19? Clin Exp Pharmacol 2020;47:1765&#x2013;1767.</Citation><ArticleIdList><ArticleId IdType="pubmed">32459003</ArticleId></ArticleIdList></Reference><Reference><Citation>Trompette A, Gollwitzer ES, Pattaroni C, et al. . Dietary fiber confers protection against flu by shaping Ly6c(-) patrolling monocyte hematopoiesis and CD8(+) T cell metabolism. Immunity 2018;48:992&#x2013;1005.e1008.</Citation><ArticleIdList><ArticleId IdType="pubmed">29768180</ArticleId></ArticleIdList></Reference><Reference><Citation>Varanasi SK, Donohoe D, Jaggi U, et al. . Manipulating glucose metabolism during different stages of viral pathogenesis can have either detrimental or beneficial effects. J Immunol Res 2017;199:1748&#x2013;1761.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5584583</ArticleId><ArticleId IdType="pubmed">28768727</ArticleId></ArticleIdList></Reference><Reference><Citation>Vastag L, Koyuncu E, Grady SL, et al. . Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism. PLoS Pathog 2011;7:e1002124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3136460</ArticleId><ArticleId IdType="pubmed">21779165</ArticleId></ArticleIdList></Reference><Reference><Citation>Verucchi G, Calza L, Manfredi R, et al. . Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Infection 2004;32:33&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">15007741</ArticleId></ArticleIdList></Reference><Reference><Citation>Villar J, Ferrando C, Mart&#xed;nez D, et al. . Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med 2020;8:267&#x2013;276.</Citation><ArticleIdList><ArticleId IdType="pubmed">32043986</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, et al. . Diverse functional autoantibodies in patients with COVID-19. Nature 2021;595:283&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Dai T, Qin Z, et al. . Targeting liquid&#x2013;liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity. Nat Cell Biol 2021;23:718&#x2013;732.</Citation><ArticleIdList><ArticleId IdType="pubmed">34239064</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Li W, Hui H, et al. . Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol. EMBO J 2020;39:e106057&#x2013;e106057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537045</ArticleId><ArticleId IdType="pubmed">32944968</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Ma P, Zhang S, et al. . Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study. Diabetologia 2020;63:2102&#x2013;2111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7347402</ArticleId><ArticleId IdType="pubmed">32647915</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei X, Zeng W, Su J, et al. . Hypolipidemia is associated with the severity of COVID-19. J Clin Lipidol 2020;14:297&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7192140</ArticleId><ArticleId IdType="pubmed">32430154</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels I, Rolles B, and Rink L. The potential impact of zinc supplementation on COVID-19 pathogenesis. Front Immunol 2020;11:1712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7365891</ArticleId><ArticleId IdType="pubmed">32754164</ArticleId></ArticleIdList></Reference><Reference><Citation>West J, Everden S, and Nikitas N. A case of COVID-19 reinfection in the UK. Clin Med (Lond) 2021;21:e52&#x2013;e53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850175</ArticleId><ArticleId IdType="pubmed">33303623</ArticleId></ArticleIdList></Reference><Reference><Citation>Yavuz S, and &#xdc;nal S. Antiviral treatment of COVID-19. Turk J Med Sci 2020;50:611&#x2013;619.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195979</ArticleId><ArticleId IdType="pubmed">32293834</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu B, Li C, Sun Y, et al. . Insulin treatment is associated with increased mortality in patients with COVID-19 and type 2 diabetes. Cell Metab 2021;33:65&#x2013;77.e62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7682421</ArticleId><ArticleId IdType="pubmed">33248471</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaim S, Chong JH, Sankaranarayanan V, et al. . COVID-19 and multiorgan response. Curr Probl Cardiol 2020;45:100618&#x2013;100618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7187881</ArticleId><ArticleId IdType="pubmed">32439197</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarrilli G, Angerilli V, Businello G, et al. . The immunopathological and histological landscape of COVID-19-mediated lung injury. Int J Mol Sci 2021;22:974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7835817</ArticleId><ArticleId IdType="pubmed">33478107</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Gan R, Zhen Z, et al. . Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals. Signal Transduct Target Ther 2020;5:156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7426596</ArticleId><ArticleId IdType="pubmed">32796814</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Geng X, Tan Y, et al. . New understanding of the damage of SARS-CoV-2 infection outside the respiratory system. Biomed Pharmacother 2020;127:110195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7186209</ArticleId><ArticleId IdType="pubmed">32361161</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Yu X, Chen H, et al. . Leptin deficiency shifts mast cells toward anti-inflammatory actions and protects mice from obesity and diabetes by polarizing M2 macrophages. Cell Metab 2015;22:1045&#x2013;1058.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4670585</ArticleId><ArticleId IdType="pubmed">26481668</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N, Wang W, Liu Z, et al. . Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells. Nat Commun 2020;11:3910.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7413383</ArticleId><ArticleId IdType="pubmed">32764693</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Ramos da Silva S, He M, et al. . An oncogenic virus promotes cell survival and cellular transformation by suppressing glycolysis. PLoS Pathog 2016;12:e1005648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4871371</ArticleId><ArticleId IdType="pubmed">27187079</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu S, Deng Y-Q, Zhou C, et al. . 25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor. Cell Res 2020;30:1043&#x2013;1045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7431750</ArticleId><ArticleId IdType="pubmed">32811977</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>